Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MABT110 Anti-Aggrecan (neoepitope) Antibody, clone BC-3

Anti-Aggrecan (neoepitope) Antibody, clone BC-3 detects level of Aggrecan (neoepitope) & has been published & validated for use in Western Blotting & IHC.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Cell Structure Research Sub-Category: ECM Proteins Gene Symbol: ACAN, AGC1, CSPG1, MSK16 UniProt Number: P16112
MABT110
100 µg  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Special Offers

100% Performance Guaranteed

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
B, HWB, IHCMPurifiedMonoclonal Antibody
Description
Catalogue NumberMABT110
DescriptionAnti-Aggrecan (neoepitope) Antibody, clone BC-3
Alternate Names
  • Aggrecan core protein
  • Cartilage-specific proteoglycan core protein
  • CSPCP
  • Chondroitin sulfate proteoglycan core protein 1
  • Chondroitin sulfate proteoglycan 1
  • Aggrecan core protein 2
Background InformationAggrecan (CSPG1, CSPCP, or CSPGCP) is a chondroitin-sulfate proteoglycan belonging to the family of letican proteins. Aggrecan is a large globar structure containing multiple domains including carbohydrate-recognition domains; complement binding protein domains; immunoglobulin domains; proteoglycan tandem repeats; and in some cases, EGF-like domains. It can be degraded by aggrecanase. The N-terminus of aggrecan binds ECM hyaluronan in the presence of the linking protein, and forms complex aggregates, whereas the C-terminus binds a number of other ECM proteins including tenascins, glycolipids, and fibulins. Aggrecan is a major component of cartilage tissue and it enables this tissue to withstand compression by maintaining the viso-elastic properties of cartilage. Aggrecan may also facilitate neural maturation and plasticity by contributing to the formation of perineuronal nets in the developing CNS.
References
Product Information
FormatPurified
Control
  • SW1353 cell lysate
PresentationPurified mouse monoclonal IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-Aggrecan (neoepitope) Antibody, clone BC-3 detects level of Aggrecan (neoepitope) & has been published & validated for use in Western Blotting & IHC.
Key Applications
  • Western Blotting
  • Immunohistochemistry
Application NotesWestern Blot Analysis: A representative lot detected Aggrecan neoepitope in human chondrocite cell lysate.
Biological Information
ImmunogenLinear peptide corresponding to human Aggrecan neoepitope.
EpitopeArgs neoepitope sequence
CloneBC-3
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostMouse
SpecificityThis antibody detectes the Args neoepitope sequence in aggrecanase-cleaved aggrecan (Tortella, M. D., et al. (1999). Science. 284(5420):1664-1666.).
IsotypeIgG1κ
Species Reactivity
  • Bovine
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene is a member of the aggrecan/versican proteoglycan family. The encoded protein is an integral part of the extracellular matrix in cartilagenous tissue and it withstands compression in cartilage. Mutations in this gene may be involved in skeletal dysplasia and spinal degeneration. Multiple alternatively spliced transcript variants that encode different protein isoforms have been observed in this gene.
Gene Symbol
  • ACAN
  • AGC1
  • CSPG1
  • MSK16
Purification MethodProtein G Purified
UniProt Number
UniProt SummaryFUNCTION: This proteoglycan is a major component of extracellular matrix of cartilagenous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region.

SUBUNIT STRUCTURE: Interacts with FBLN1. Interacts with COMP.

TISSUE SPECIFICITY: Restricted to cartilages.

DEVELOPMENTAL STAGE: Expression was detected in chondrocytes throughout the developing skeleton.

DOMAIN: Two globular domains, G1 and G2, comprise the N-terminus of the proteoglycan, while another globular region, G3, makes up the C-terminus. G1 contains Link domains and thus consists of three disulfide-bonded loop structures designated as the A, B, B' motifs. G2 is similar to G1. The keratan sulfate (KS) and the chondroitin sulfate (CS) attachment domains lie between G2 and G3.

POST-TRANSLATIONAL MODIFICATION: Contains mostly chondroitin sulfate, but also keratan sulfate chains, N-linked and O-linked oligosaccharides. The release of aggrecan fragments from articular cartilage into the synovial fluid at all stages of human osteoarthritis is the result of cleavage by aggrecanase.

INVOLVEMENT IN DISEASE: Defects in ACAN are the cause of spondyloepiphyseal dysplasia type Kimberley (SEDK). Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. Defects in ACAN are the cause of spondyloepimetaphyseal dysplasia aggrecan type (SEMD-ACAN). A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. Defects in ACAN are the cause of osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]. It is a type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis.

SEQUENCE SIMILARITIES: Belongs to the aggrecan/versican proteoglycan family. Contains 1 C-type lectin domain. Contains 1 EGF-like domain. Contains 1 Ig-like V-type (immunoglobulin-like) domain. Contains 4 Link domains. Contains 1 Sushi (CCP/SCR) domain.
Molecular Weight~60 kDa observed. Uniprot describes three isoforms at ~250 kDa, ~246 kDa and ~239 kDa. Aggrecan is degraded by aggrecanase into a ~60 kDa protein and other higher molecular weight products (Lemons, M. L. et al. (2001). J Neurosci. 21(13):4772-4781. Forsang, A. J. et al. (1995). Biochem J. 310(Pt 1):337-343.).
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blot in SW1353 cell lysate.

Western Blot Analysis:1 µg/mL of this antibody detected Aggrecan neoepitope in 10 µg of SW1353 cell lysate.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
MABT110 04053252644467

Documentation

Anti-Aggrecan (neoepitope) Antibody, clone BC-3 SDS

Title

Safety Data Sheet (SDS) 

Anti-Aggrecan (neoepitope) Antibody, clone BC-3 Certificates of Analysis

TitleLot Number
Anti-Aggrecan (neoepitope), clone BC-3 - 2382218 2382218
Anti-Aggrecan (neoepitope), clone BC-3 - 2421834 2421834
Anti-Aggrecan (neoepitope), clone BC-3 2480949
Anti-Aggrecan (neoepitope), clone BC-3 - 3503438 3503438
Anti-Aggrecan (neoepitope), clone BC-3 - 3761086 3761086
Anti-Aggrecan (neoepitope), clone BC-3 - 4070093 4070093
Anti-Aggrecan (neoepitope), clone BC-3 - Q2006985 Q2006985
Anti-Aggrecan (neoepitope), clone BC-3 Monoclonal Antibody 2942466
Anti-Aggrecan (neoepitope), clone BC-3 Monoclonal Antibody 2885481
Anti-Aggrecan (neoepitope), clone BC-3 Monoclonal Antibody 3098933

Related Products & Applications

Related Products

Catalogue Number Description
AB1031 Anti-Aggrecan Antibody
AP128P Goat Anti-Mouse IgM Antibody, µ chain, HRP conjugate
MABT83 Anti-Aggrecan Antibody, clone 6B4
MABT84 Anti-Aggrecan Antibody, clone 1-C-6
MAB1581 Anti-Chondroitin Sulfate Proteoglycan Antibody, Core Protein Epitope, clone Cat-315
MAB19310 Anti-Aggrecan Antibody, MMP Cleaved, NT FFGVG neoepitopes, clone AF-28
MAB19310-C Anti-Aggrecan Antibody, MMP Cleaved, clone AF-28, Ascites Free
MAB2015 Anti-Cartilage Proteoglycan Antibody, adult, clone EFG-4
MAB2035 Anti-Chondroitin 6 Sulfate Antibody, clone MK-302
MAB5284 Anti-Chondroitin Sulfate Proteoglycan Antibody, Brain (core protein), clone Cat-301
Show more

Product Families

Chondrocyte Specific Markers

Chondrocytes are the only cells found in healthy cartilage. They produce and maintain the cartilaginous matrix, which consists mainly of collagen and proteoglycans.
Learn More >>

Categories

Life Science Research > Antibodies and Assays > Primary Antibodies